#AHA25 Late Breaker iSense diagnosing angiographic obstructive CAD including occlusion MI with AUC of 0.87, specificity 90%, PPV 84%; Freedom from ACS over 30 days with AUC of 0.89, sensitivity 99%, NPV 96%
🎄🎅♥️🫀Season’s greetings from RCE!
2025 will be big for us—thank you for 6 years of belief. Wishing you joy, health, and success in the new year!
1
1
36
#aha2024 has been great so far! Looking forward to our CEO speaking tomorrow and meeting with many of you!
#MedTech #HealthcareInnovation #Cardiology #EmergencyCare #MedicalDevices
#hearthealth #cardiaccare #earlydetection #heartattack #medicaltechnology #rce #heartattack
Only 1 week to go! Meet me at AHA 2024! #AHA24 #Cardiology #HealthTech #MedTech #HealthcareInnovation
1
35
Over 10M Americans visit the ER yearly fearing a heart attack, but 80% aren’t. They still face hours of tests. RCE’s non-invasive wearable could give results in 3 minutes—no blood draw needed—even in an ambulance, saving time & $$, and focusing critical care on those who need it.
3
37
RCE retweeted
Congratulations to the 2nd Place Winner of the #HRX2024 Pitch Competition - RCE!
@HRSonline @HeartRhythmTV @jenniferavari @drsuneet
RCE retweeted
Immediately following the #HRX2024 Pitch Competition, Executive Producer @jenniferavari and Producer @drsuneet talked with 2nd Place Winner, rce.ai, to discuss their winning pitch. See the full interview here #EPeeps ➡️ bit.ly/4dRVQUt
To learn more about RCE, visit rce.ai/
RCE retweeted
An underutilized marker of CVD risk @BiomarkerSymp
Highlights from a First-In-Human transdermal continuous monitoring reveal real-time biomarker trends from RCE’s wrist wearable. #ACC24
einnews.com/pr_news/70476232…
Winning the #aha23 health tech award is a testament to the hard work, dedication, and passion that drives our team’s commitment to the field of #cardiovascular #medicine and our mission to save human lives by early detection of heart injury.
RCE retweeted
Congrats to the amazing companies who participated in this year’s Health Tech Competition at #AHA23. @StarJonesEsq said it best: I hope one day there’s a patient on this stage talking about how your solution saved my life. This year’s winners: @PyramesInc @Cardiosense @rce_ai
🏆 Exciting News from #ScientificSessions2023! 🚀 RCE is the winner of the AHA 2023 Health Tech Competition, showcasing groundbreaking innovation in heart attack diagnostics🌐 newsroom.heart.org/news/winn… #HeartAttack #HeartHealth #Innovation #ScientificSessions🌟
🚨 Exciting update from RCE Technologies Inc! We're exploring new frontiers in cardiac arrest care with Tropsensor, a transdermal troponin measurement using infrared optical tech. 🚑 #AHA2023 #CardiacCare #Innovation #EmergencyMedicine @JittoTitus @grahamnichol
The votes are in! We’re excited to be finalists in the #AHA23 Center for Health
Technology & Innovation Health Tech Competition!
ahascientificsessions-2023.o…
RCE retweeted
I don’t think my work has ever been cited this much in a year, let alone a single day- looks like some speakers are definitely getting invited back next year!!! 😂‼️@ChrisDefilippi @yadersandoval @alan_maisel @BiomarkerSymp
Thank you @loridanielsmd @alan_maisel for the opportunity to participate at the 17th Annual Biomarkers Symposium. @BiomarkerSymp
RCE retweeted
A groundbreaking development in the remote detection of acute MI! Read it in the European Heart Journal - Digital Health https://xitter.gq/t.co/YxCIPYgLyM, editorial https://xitter.gq/t.co/AiHt7fCwhz and watch ESC TV >March 23rd at 18:00 (CET) https://xitter.gq/t.co/vpVM3OXkKc
@escardio @ESC_Journals
RCE retweeted
Incredible work by the @rce_ai team and @ppsengupta1 #transformative #innovation #troponin @ACCinTouch
ESC TV On the Road 🚍 at #ACC23
.@ppsengupta1 shares the breakthroughs in wrist-Wwrn transdermal troponin-I-sensor assessment for acute myocardial infarction.
























